Cargando…
Trends of rapamycin in survival benefits of liver transplantation for hepatocellular carcinoma
The proportion of liver transplantation (LT) for hepatocellular carcinoma (HCC) has kept on increasing over the past years and account for 20%-40% of all LT. Post-transplant HCC recurrence is considered the most important factor affecting the long-term survival of patients. The use of different type...
Autores principales: | Zhao, Yang, Liu, Yu, Zhou, Lin, Du, Guo-Sheng, He, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462078/ https://www.ncbi.nlm.nih.gov/pubmed/34621472 http://dx.doi.org/10.4240/wjgs.v13.i9.953 |
Ejemplares similares
-
Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons
por: Luo, Yi, et al.
Publicado: (2022) -
Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma
por: Yang, Po-Chih, et al.
Publicado: (2016) -
Liver transplantation for hepatocellular carcinoma: Where do we stand?
por: Santopaolo, Francesco, et al.
Publicado: (2019) -
Anatomical resection of hepatocellular carcinoma: A critical review of the procedure and its benefits on survival
por: Kang, Koo Jeong, et al.
Publicado: (2017) -
Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions
por: Pavel, Mihai-Calin, et al.
Publicado: (2018)